共 50 条
- [41] Rapidly progressive erosions and ulcerations in a patient with cancer-associated anti-TIF-1γ/α and anti-U1 RNP-positive dermatomyositis: A case reportJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1403 - E1404Rosseels, W.Vulsteke, J. B.Bosisio, F.Satoh, M.De Langhe, E.De Haes, P.
- [42] A Simple Risk Score to Predict the Presence of NSN Metastases in Breast Cancer Patients With a Positive Sentinel NodeEUROPEAN JOURNAL OF CANCER, 2011, 47 : S343 - S343van la Parra, R.Peer, P. G. M.de Roos, W.Ernst, M. F.Bosscha, K.
- [43] Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositisJOURNAL OF DERMATOLOGY, 2020, 47 (12): : 1395 - 1402Motegi, Sei-ichiroSekiguchi, AkikoIkeuchi, HidekazuSakairi, ToruOgawa, HiroomiFujii, TakaakiSohda, MakotoYajima, ToshikiIda, ShotaTakayasu, YukihiroShimoda, YukiHiromura, KeijuSaeki, HiroshiShirabe, KenChikamatsu, KazuakiYokoo, HideakiOyama, TetsunariIshikawa, Osamu
- [44] Comprehensive analysis of predictive biomarkers for patients with curative colorectal cancer patients and high risk of recurrence.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)Mori, KoichiroToiyama, YujiSaigusa, SusumuNoguchi, TomofumiIde, ShozoImaoka, HirokiUratani, RyoOki, SatoshiFujikawa, HiroyukiHiro, JunichiroKobayashi, MinakoOhi, MasakiAraki, ToshimitsuInoue, YasuhiroTanaka, KojiMohri, YasuhikoKusunoki, Masato
- [45] Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancerONCOTARGETS AND THERAPY, 2016, 9 : 959 - 976Ma, BoMa, QianqianWang, HongqiangZhang, GuoleiZhang, HuiyingWang, Xiaohong
- [46] Positive biopsy rate in rebiopsies of patients with PIN: Is the risk of cancer as high as we think?RADIOLOGY, 2000, 217 : 364 - 364O'Neill, MJGervais, DMcGovern, FJAlthausen, AFMueller, PR
- [47] Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 PatientsFRONTIERS IN IMMUNOLOGY, 2022, 13Zhao, LijuanXie, ShuoshanZhou, BinShen, ChuyuLi, LiyaPi, WeiweiGong, ZhenZhao, JingPeng, QiZhou, JunyuPeng, JiaqiZhou, YanZou, LingxiaoSong, LiangZhu, HonglinLuo, Hui
- [48] Cystectomy or conservative therapy for patients with high-risk, T1G3 bladder cancer? Nature Clinical Practice Urology, 2008, 5 (1): : 6 - 7
- [49] Tissue biomarkers in patients with high-risk prostate cancer treated with neoadjuvant chemohormonal therapyCANCER SCIENCE, 2018, 109 : 1023 - 1023Narita, ShintaroNara, TaketoshiChiba, SyujiKanda, SoheiNumakura, KazuyukiSaito, MitsuruInoue, TakamitsuHuang, MingguoNanjo, HiroshiHabuchi, Tomonori
- [50] Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (09) : 735.e9 - 735.e15Yang, David D.Muralidhar, VinayakMahal, Brandon A.Vastola, Marie E.Boldbaatar, NinjinLabe, Shelby A.Nezolosky, Michelle D.Martin, Neil E.King, Martin T.Mouw, Kent W.Choueiri, Toni K.Trinh, Quoc-DienNguyen, Paul L.Orio, Peter F., III